We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

46 hedge funds and large institutions have $19M invested in T2 Biosystems, Inc in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more capital invested

Capital invested by funds: $7.39M → $19M (+$11.6M)

154% more call options, than puts

Call options by funds: $553K | Put options by funds: $218K

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

18% more funds holding

Funds holding: 3946 (+7)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

Holders
46
Holders Change
+7
Holders Change %
+17.95%
% of All Funds
0.94%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
9
Reduced
11
Closed
7
Calls
$553K
Puts
$218K
Net Calls
+$335K
Net Calls Change
+$354K

TTOO Hedge Fund Activity: Q2 2020 in Review

46 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2020, worth a combined $19M — up 157% from $7.39M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new TTOO positions and 7 closed out — a net gain of 8 holders — while 9 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.17M. The largest seller was GSA Capital Partners, cutting an estimated $297K.

  • 46 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2020, up from 39 in Q1 2020.
  • Funds reported $19M of T2 Biosystems, Inc stock for Q2 2020, up 157% quarter-over-quarter.
  • 15 funds opened new T2 Biosystems, Inc positions in Q2 2020 and 7 closed out, a net change of +8 holders.
  • The largest T2 Biosystems, Inc buyer in Q2 2020 was Vanguard Group, an estimated $2.17M added.
  • The largest T2 Biosystems, Inc seller in Q2 2020 was GSA Capital Partners, an estimated $297K sold.

Based on aggregated 13F filings for Q2 2020.